Glaxo: Good Show - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Glaxo: Good Show

Apr 27, 2001

Glaxo India Ltd has posted a net profit of Rs 102 m (down 28%) for the quarter ended March 31, 2001. Net sales grew by 6.1% to Rs 1,944 m compared to Rs 1,832 m in the corresponding period last fiscal. Operating margins showed a significant improvement, increasing by more than 60 basis points. The dip in net profits was primarily due to comparatively lower other income. Other Income for the corresponding previous period last year included a income Rs 50 m from sale of brands. Barring Other Income, Profit Before Tax has in effect increased by more than 22.9%

(Rs m) 1QFY01 1QFY02 Change
Sales 1,832 1,944 6.1%
Other Income 130 64 -50.8%
Expenditure 1,689 1,781 5.4%
Operating Profit (EBDIT) 143 163 14.0%
Operating Profit Margin (%) 7.8% 8.4%  
Interest 21 23 9.5%
Depreciation 39 38 -2.6%
Profit before Tax 213 166 -22.1%
Other Adjustments      
Tax 72 64 -11.1%
Profit after Tax/(Loss) 141 102 -27.7%
Net profit margin (%) 7.7% 5.2%  
No. of Shares (eoy) (m) 60 60  
Diluted Earnings per share* 9.4 6.8  
P/E (at current price) 40.9 56.6  
(*- annualised)      

The company has also received approval of the shareholders to merge Smithkline Beecham Pharma with effect from 12th April 2001.

In a related development the company recently decided to expand the business activities of its animal health division by entering new areas like antibiotic and ectoparasite and nutrition segments, launching technically superior products in cattle and poultry segment besides launching line extension of existing products.The animal healthmarket in the country is estimated to be around Rs 8 bn with the poultry sector alone contributing 45%.

At the current market price of Rs 386, the stock is trading at 57 times its annualised 1QFY02 earnings.

Equitymaster requests your view! Post a comment on "Glaxo: Good Show". Click here!


More Views on News

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Dec 3, 2021 (Close)


  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks